- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Northrim BanCorp Inc: Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.34 per Share | ||
| Fr | Live Ventures Incorporated: Live Ventures CEO Completes Open Market Share Purchase | ||
| Fr | CF Energy Corp.: CF Energy Announces Financial Results For The Three-Month Period ended March 31, 2020 | ||
| Fr | Celsion CORP: Celsion Reports Data Safety Monitoring Board Recommendation to Proceed to Phase II of the OVATION 2 Study in Advanced Ovarian Cancer | ||
| Fr | Lykill fjármögnun hf.: Bond and bill auction on June 4th | ||
| Fr | Avenue Therapeutics to Host Virtual Annual Meeting of Stockholders | ||
| Fr | Braingrid Limited Provides Update on COVID-19 and Announces Request for Extension to File Annual Financial Statements and Management's Discussion and ... | ||
| Fr | Paratek Pharmaceuticals Announces Change to Time of 2020 Annual Meeting of Stockholders | ||
| Fr | Sortis Holdings, Inc.: Sortis Holdings Plays Key Role in Rescue of Seattle's Iconic Rudy's Barbershop, Helps Original Founders Regain Control | ||
| Fr | Kiniksa Pharmaceuticals, Ltd.: Kiniksa Announces Upcoming Presentation on Mavrilimumab in COVID-19 Pneumonia and Hyperinflammation at the European E-Congress ... | ||
| Fr | iFresh Inc.: iFresh Expands Online Grocery Delivery Service to Additional States | ||
| Fr | Turning Point Therapeutics, Inc.: Turning Point Therapeutics Presents Preclinical Data For Novel RET Inhibitor Candidate, TPX-0046 | ||
| Fr | Agios Pharmaceuticals, Inc.: Agios Presents Updated Data from the Phase 1 Dose-escalation Study of Vorasidenib in Patients with IDH-mutant Non-enhancing ... | ||
| Fr | RAPT Therapeutics, Inc.: RAPT Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology Virtual Scientific Program | ||
| Fr | BeiGene, LTD.: BeiGene Presents Updated Head to Head Results from Phase 3 Trial of Zanubrutinib vs. Ibrutinib in Patients with Waldenström's Macroglobulinemia ... | ||
| Fr | Feronia Inc. Advises on Timing of Filing Interim Financial Statements and Management's Discussion and Analysis | ||
| Fr | Larimar Therapeutics, Inc.: Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics | ||
| Fr | NextCure Presents Biomarker Data and Updated Clinical Results from Phase 1 Portion of its NC318 Clinical Trial at the 2020 Virtual American Society of ... | ||
| Fr | Kiadis Pharma N.V.: Kiadis announces new data related to its K-NK cell therapy platform presented today at the ASCO 2020 Virtual Annual Meeting | ||
| Fr | Affimed N.V.: Affimed Highlights Study Design of its AFM13 REDIRECT Trial at the ASCO 2020 Virtual Meeting | ||
| Fr | CytomX Therapeutics Inc.: CytomX Therapeutics Clinical Programs Highlighted at American Society of Clinical Oncology ASCO20 Virtual Scientific Program | ||
| Fr | Iovance Biotherapeutics Inc: Iovance Presents Updated Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapy Lifileucel in Advanced Melanoma at ... | ||
| Fr | Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose Escalation Trial for the PSMA-targeting TriTAC HPN424 at the ASCO20 Virtual Scientific ... | ||
| Fr | AS Tallinna Sadam: Lifting of restrictions on passenger movement to Estonia for citizens of European countries | ||
| Fr | Autolus Limited: Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ASCO20 Virtual Scientific Program |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
